Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    May 2018
  1. KELLER FG, Castellino SM, Chen L, Pei Q, et al
    Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group.
    Cancer. 2018 May 8. doi: 10.1002/cncr.31519.
    PubMed     Text format     Abstract available


  2. ROMAGUERA JE, Wang M, Feng L, Fayad LE, et al
    Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.
    Cancer. 2018 May 3. doi: 10.1002/cncr.31361.
    PubMed     Text format     Abstract available


    April 2018
  3. ARTS LPJ, Oerlemans S, Tick L, Koster A, et al
    More frequent use of health care services among distressed compared with nondistressed survivors of lymphoma and chronic lymphocytic leukemia: Results from the population-based PROFILES registry.
    Cancer. 2018 Apr 26. doi: 10.1002/cncr.31410.
    PubMed     Text format     Abstract available


  4. SMITH SM, Godfrey J, Ahn KW, DiGilio A, et al
    Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
    Cancer. 2018 Apr 12. doi: 10.1002/cncr.31374.
    PubMed     Text format     Abstract available


  5. LYNCH RC, Gopal AK
    Have we found the right patient population for transplantation in follicular lymphoma?
    Cancer. 2018 Apr 12. doi: 10.1002/cncr.31376.
    PubMed     Text format    


    March 2018
  6. GREENWELL IB, Staton AD, Lee MJ, Switchenko JM, et al
    Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31328.
    PubMed     Text format     Abstract available


    February 2018

  7. Erratum: Epperla N, Maddocks KJ, Salhab M, et al. C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy. Cancer. 2017;123:4411-4418.
    Cancer. 2018;124:867.
    PubMed     Text format    


  8. SUREDA A, Zhang MJ, Dreger P, Carreras J, et al
    Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
    Cancer. 2018 Feb 9. doi: 10.1002/cncr.31264.
    PubMed     Text format     Abstract available


    December 2017
  9. PRINTZ C
    First person: Julie Vose, MD, MBA: The lymphoma specialist is focused on patients as well as organizational leadership.
    Cancer. 2017;123:4749.
    PubMed     Text format    


    November 2017
  10. MYERS RM, Hill BT, Shaw BE, Kim S, et al
    Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
    Cancer. 2017 Nov 10. doi: 10.1002/cncr.31114.
    PubMed     Text format     Abstract available


  11. ARMENIAN SH, Mertens L, Slorach C, Venkataraman K, et al
    Prevalence of anthracycline-related cardiac dysfunction in long-term survivors of adult-onset lymphoma.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31110.
    PubMed     Text format     Abstract available


  12. AMMANN EM, Drake MT, Haraldsson B, Wallace RB, et al
    Incidence of hematologic malignancy and cause-specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementation.
    Cancer. 2017;123:4168-4177.
    PubMed     Text format     Abstract available


  13. FRICK MA, Vachani CC, Bach C, Hampshire MK, et al
    Survivorship and the chronic cancer patient: Patterns in treatment-related effects, follow-up care, and use of survivorship care plans.
    Cancer. 2017;123:4268-4276.
    PubMed     Text format     Abstract available


    October 2017
  14. MAJZNER RG, Simon JS, Grosso JF, Martinez D, et al
    Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues.
    Cancer. 2017;123:3807-3815.
    PubMed     Text format     Abstract available


    September 2017
  15. HAN CH, Batchelor TT
    Diagnosis and management of primary central nervous system lymphoma.
    Cancer. 2017 Sep 26. doi: 10.1002/cncr.30965.
    PubMed     Text format     Abstract available


  16. EHRHARDT MJ, Mulrooney DA, Li C, Baassiri MJ, et al
    Neurocognitive, psychosocial, and quality-of-life outcomes in adult survivors of childhood non-Hodgkin lymphoma.
    Cancer. 2017 Sep 15. doi: 10.1002/cncr.31019.
    PubMed     Text format     Abstract available


  17. HENDERSON TO, Parsons SK, Wroblewski KE, Chen L, et al
    Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.
    Cancer. 2017 Sep 13. doi: 10.1002/cncr.30979.
    PubMed     Text format     Abstract available


    August 2017
  18. MEDHANIE GA, Fedewa SA, Adissu H, DeSantis CE, et al
    Cancer incidence profile in sub-Saharan African-born blacks in the United States: Similarities and differences with US-born non-Hispanic blacks.
    Cancer. 2017;123:3116-3124.
    PubMed     Text format     Abstract available


    July 2017
  19. YANIK EL, Shiels MS, Smith JM, Clarke CA, et al
    Contribution of solid organ transplant recipients to the pediatric non-hodgkin lymphoma burden in the United States.
    Cancer. 2017 Jul 31. doi: 10.1002/cncr.30923.
    PubMed     Text format     Abstract available


  20. EPPERLA N, Maddocks KJ, Salhab M, Chavez JC, et al
    C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy.
    Cancer. 2017 Jul 27. doi: 10.1002/cncr.30895.
    PubMed     Text format     Abstract available


  21. ALVAREZ E, Keegan T, Johnston EE, Haile R, et al
    Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers.
    Cancer. 2017;123:2516-2523.
    PubMed     Text format     Abstract available


    June 2017
  22. HUI L, von Keudell G, Wang R, Zeidan AM, et al
    Cost-effectiveness analysis of consolidation with brentuximab vedotin for high-risk Hodgkin lymphoma after autologous stem cell transplantation.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30818.
    PubMed     Text format     Abstract available


  23. CARBONE A, Gloghini A
    Hodgkin lymphoma classification: Are we at a crossroads?
    Cancer. 2017 Jun 16. doi: 10.1002/cncr.30824.
    PubMed     Text format    


  24. PROVENCIO M, Royuela A, Torrente M, Pollan M, et al
    Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group.
    Cancer. 2017 Jun 13. doi: 10.1002/cncr.30795.
    PubMed     Text format     Abstract available


    May 2017
  25. RAJAGOPAL R, Miles GCP, Kotecha RS
    High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for pediatric primary central nervous system lymphoma in first complete remission.
    Cancer. 2017 May 23. doi: 10.1002/cncr.30768.
    PubMed     Text format    


  26. LIN CJ, Vader JM, Slade M, DiPersio JF, et al
    Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation.
    Cancer. 2017;123:1800-1809.
    PubMed     Text format     Abstract available


  27. LEHMANN V, Tuinman MA, Keim MC, Winning AM, et al
    Psychosexual development and satisfaction in long-term survivors of childhood cancer: Neurotoxic treatment intensity as a risk indicator.
    Cancer. 2017;123:1869-1876.
    PubMed     Text format     Abstract available


  28. GHAZAWI FM, Netchiporouk E, Rahme E, Tsang M, et al
    Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
    Cancer. 2017 May 10. doi: 10.1002/cncr.30758.
    PubMed     Text format     Abstract available


  29. KOFF JL, Flowers CR
    Prognostic modeling in diffuse large B-cell lymphoma in the era of immunochemotherapy: Where do we go from here?
    Cancer. 2017 May 2. doi: 10.1002/cncr.30740.
    PubMed     Text format    


  30. HOWLADER N, Mariotto AB, Besson C, Suneja G, et al
    Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era.
    Cancer. 2017 May 2. doi: 10.1002/cncr.30739.
    PubMed     Text format     Abstract available


    April 2017
  31. VARGO JA, Patel A, Glaser SM, Balasubramani GK, et al
    The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States.
    Cancer. 2017 Apr 5. doi: 10.1002/cncr.30697.
    PubMed     Text format     Abstract available


  32. DEFILIPP Z, Li S, El-Jawahri A, Armand P, et al
    High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
    Cancer. 2017 Apr 3. doi: 10.1002/cncr.30695.
    PubMed     Text format     Abstract available


    March 2017
  33. METSER U, Dudebout J, Baetz T, Hodgson DC, et al
    [18 F]-FDG PET/CT in the staging and management of indolent lymphoma: A prospective multicenter PET registry study.
    Cancer. 2017 Mar 13. doi: 10.1002/cncr.30672.
    PubMed     Text format     Abstract available


    February 2017
  34. ZITO MARINO F, Rossi G, Brunelli M, Malzone MG, et al
    Diagnosis of anaplastic lymphoma kinase rearrangement in cytological samples through a fluorescence in situ hybridization-based assay: Cytological smears versus cell blocks.
    Cancer. 2017 Feb 14. doi: 10.1002/cncy.21835.
    PubMed     Text format     Abstract available


  35. MANYAM BV, Garsa AA, Chin RI, Reddy CA, et al
    A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Cancer. 2017 Feb 7. doi: 10.1002/cncr.30601.
    PubMed     Text format     Abstract available



  36. First Person: Clara Bloomfield, MD.
    Cancer. 2017;123:369-370.
    PubMed     Text format    


    January 2017
  37. EL-JAWAHRI A, Chen YB, Brazauskas R, He N, et al
    Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    Cancer. 2017 Jan 19. doi: 10.1002/cncr.30546.
    PubMed     Text format     Abstract available


    December 2016
  38. MILGROM SA, Jauhari S, Plastaras JP, Nieto Y, et al
    A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
    Cancer. 2016 Dec 16. doi: 10.1002/cncr.30482.
    PubMed     Text format     Abstract available


  39. TAKEUCHI T, Yamaguchi M, Kobayashi K, Miyazaki K, et al
    MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
    Cancer. 2016 Dec 4. doi: 10.1002/cncr.30404.
    PubMed     Text format     Abstract available


  40. HORWITZ SM, Pinter-Brown LC, Rosen ST, Pro B, et al
    A prospective cohort study of patients with peripheral T-cell lymphoma in the United States.
    Cancer. 2016 Dec 2. doi: 10.1002/cncr.30416.
    PubMed     Text format     Abstract available


    November 2016
  41. SHARMA S, Dey P, Mitra S, Rajwanshi A, et al
    Nodular sclerosis classical Hodgkin lymphoma grade 2: A diagnostic challenge to the cytopathologists.
    Cancer. 2016 Nov 21. doi: 10.1002/cncy.21799.
    PubMed     Text format     Abstract available


    June 2016
  42. BARTA SK, Li H, Hochster HS, Hong F, et al
    Randomized phase 3 study in low-grade lymphoma comparing maintenance anti-CD20 antibody with observation after induction therapy: A trial of the ECOG-ACRIN Cancer Research Group (E1496).
    Cancer. 2016 Jun 28. doi: 10.1002/cncr.30137.
    PubMed     Text format     Abstract available


  43. CHIHARA D, Westin JR, Oki Y, Ahmed MA, et al
    Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.
    Cancer. 2016 Jun 28. doi: 10.1002/cncr.30173.
    PubMed     Text format     Abstract available


  44. OLSZEWSKI AJ, Fallah J, Castillo JJ
    Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base.
    Cancer. 2016 Jun 23. doi: 10.1002/cncr.30112.
    PubMed     Text format     Abstract available


  45. KAHN JM, Keegan TH, Tao L, Abrahao R, et al
    Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.
    Cancer. 2016 Jun 10. doi: 10.1002/cncr.30089.
    PubMed     Text format     Abstract available


    May 2016
  46. NIETO Y, Valdez BC, Thall PF, Jones RB, et al
    Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.
    Cancer. 2016 May 20. doi: 10.1002/cncr.30100.
    PubMed     Text format     Abstract available


  47. GO RS, Al-Hamadani M, Shah ND, Crowson CS, et al
    Influence of the treatment facility volume on the survival of patients with non-Hodgkin lymphoma.
    Cancer. 2016 May 16. doi: 10.1002/cncr.30038.
    PubMed     Text format     Abstract available


  48. COHEN JB, Han X, Jemal A, Ward EM, et al
    Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphoma.
    Cancer. 2016 May 6. doi: 10.1002/cncr.30068.
    PubMed     Text format     Abstract available


    February 2016
  49. LEIBA M, Leiba A, Keinan-Boker L, Avigdor A, et al
    Adolescent weight and height are predictors of specific non-Hodgkin lymphoma subtypes among a cohort of 2,352,988 individuals aged 16 to 19 years.
    Cancer. 2016 Feb 22. doi: 10.1002/cncr.29792.
    PubMed     Text format     Abstract available


    December 2015
  50. EL-JAWAHRI AR, Vandusen HB, Traeger LN, Fishbein JN, et al
    Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation.
    Cancer. 2015 Dec 9. doi: 10.1002/cncr.29818.
    PubMed     Text format     Abstract available


    November 2015
  51. LANDSBURG DJ, Petrich AM, Abramson JS, Sohani AR, et al
    Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Cancer. 2015 Nov 13. doi: 10.1002/cncr.29781.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: